The DOI matches its Crossref record, with a small difference in title or year; 61 of the 62 references it cites were found in a registry or an index.
Impact of Lipids on Cardiovascular Health
Open accessAbstract
People who maintain ideal cardiovascular heath have a low lifetime risk of cardiovascular disease. Therefore, encouraging people to achieve ideal cardiovascular health represents an important opportunity to improve the prevention of cardiovascular disease. However, preventing cardiovascular disease by promoting ideal cardiovascular health requires shifting the focus from treating disease after it develops to preventing cardiovascular events before they happen by slowing the progression of atherosclerosis. Because atherogenic lipoproteins play a central causal role in the initiation and progression of atherosclerosis, maintaining optimal lipid levels is necessary to achieve ideal cardiovascular health. This review describes the cumulative effect of lipid-carrying lipoproteins on the risk of cardiovascular disease, estimates the magnitude of the clinical benefit that can be achieved by maintaining optimal lipid levels, identifies the most effective timing for implementing strategies designed to achieve optimal lipid levels, and provides a clinical pathway to help people achieve the lipid levels necessary for ideal cardiovascular health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ApoB-containing lipoproteins retained in the arterial wall provoke a complex process that leads to lipid deposition and the initiation of an atheroma [43].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Self-citationGeneral Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Self-citationA Clinical Trial of the Effects of Dietary Patterns on Blood Pressure
Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., Bray, G. A., Vogt, T. M., Cutler, J. A., Windhauser, M. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361601 · Cited by 5,981
Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797
Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440101 · Cited by 5,638
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
Cited by
Sorted by citations
Items 501–510 of 510
Heart Failure and Neurocognitive Disorders: A Narrative Review
Lin, S., Wang, Q., & Cao, J. (2026) · Circulation Heart Failure · doi:10.1161/circheartfailure.126.014265
Serikawa, N., Yoshikawa, M., Arashi, H., Shibahashi, E., Otsuki, H., Kawada‐Watanabe, E., Ogawa, H., Yamaguchi, J., & Hagiwara, N. (2026) · International Journal of Cardiology · doi:10.1016/j.ijcard.2026.134781
Genetic and Conventional Risk Stratification Are Complementary for Primary Prevention of CAD
Roberts, R., & Roberts, M. (2026) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.1851
Li, X., Li, M., Wang, Y., Yue, L., & Ma, P. (2026) · Advanced Chinese Medicine · doi:10.2738/acm.2026.0013
Ye, W., Zhang, H., Xiao, N., Qiaoqi, Y., Xue, Y., & Xue, J. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-02090-4
Jacobs, J., Herbst, W., Burka, S., Tajrishi, F. Z., Tsakiris, E., Wright, L. A., & Ferdinand, K. C. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.102561
U.S. Trends in 10-Year Cardiovascular Risk Scores Over 2 Decades
Drexler, Y. R., Goldwasser, O., McCarley, C., Land, D., Naranjo, C., Mechery, V., Kulandavelu, S., Rundek, T., Yang, E., & Elfassy, T. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.103307
Faggiano, P. M., Gamberini, G., & Faggiano, A. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.121926
Lang, R., Humes, E., Lyass, A., Borowsky, L. H., Hogan, B., Kim, A. Y., LaValley, M. P., Lam, J. O., Bhar, D., Moore, R. D., et al. (2026) · HIV Medicine · doi:10.1111/hiv.70325
Reducing LDL-Cholesterol Burden in Homozygous Familial Hypercholesterolemia
Raal, F. J., & Mohamed, F. (2026) · JACC Case Reports · doi:10.1016/j.jaccas.2026.110404
Metadata
- Authors
- Ference, B. A., Graham, I., Tokgozoglu, L., & Catapano, A. L.
- Affiliations
- University of Cambridge (GB)
- Trinity College Dublin (IE)
- University of Milan (IT)
- Corresponding author
- Catapano, Alberico L.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 72
- Issue
- 10
- Pages
- 1141-1156
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2889378692
- Cited by
- 511
- References
- 62
- Citations by year
- 2026: 65 · 2025: 75 · 2024: 82 · 2023: 80 · 2022: 68 · 2021: 76 · 2020: 35 · 2019: 29 · 2018: 1
- FWCI
- 7.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Hacettepe University Institutional Repository (hacettepe.edu.tr) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- ideal cardiovascular health, cardiovascular disease prevention, atherosclerosis, atherogenic lipoproteins, serum lipids, cardiovascular risk, care pathways
- MeSH terms
- Hypolipidemic Agents, Cardiovascular Diseases, Diet, Health Promotion, Humans, Lipids, Cholesterol, LDL, Primary Prevention, Genetic Variation, Exercise, Disease Progression, Genetic Predisposition to Disease, Atherosclerosis, Plaque, Atherosclerotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
